Based in the United States, Allakos, Inc is a startup.
Allakos, Inc. is a clinical-stage biopharmaceutical company developing antibodies targeting receptor molecules on immune effector cells involved in allergy, inflammation, tissue damage, and proliferative disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.